Prestige Consumer Healthcare Inc. (NYSE:PBH) Stock Holdings Lowered by Victory Capital Management Inc.

Victory Capital Management Inc. decreased its position in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 0.3% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 2,067,908 shares of the company's stock after selling 6,552 shares during the period. Victory Capital Management Inc. owned about 4.17% of Prestige Consumer Healthcare worth $149,096,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in PBH. Opal Wealth Advisors LLC purchased a new position in Prestige Consumer Healthcare in the 2nd quarter valued at about $26,000. Quest Partners LLC boosted its position in Prestige Consumer Healthcare by 2,826.7% during the second quarter. Quest Partners LLC now owns 439 shares of the company's stock worth $30,000 after acquiring an additional 424 shares during the last quarter. EverSource Wealth Advisors LLC raised its holdings in Prestige Consumer Healthcare by 80.6% in the 1st quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company's stock valued at $33,000 after acquiring an additional 208 shares during the last quarter. Gladius Capital Management LP purchased a new position in shares of Prestige Consumer Healthcare during the 2nd quarter worth $35,000. Finally, Northwestern Mutual Wealth Management Co. boosted its holdings in shares of Prestige Consumer Healthcare by 562.3% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 510 shares of the company's stock worth $35,000 after purchasing an additional 433 shares during the last quarter. Hedge funds and other institutional investors own 99.95% of the company's stock.

Analysts Set New Price Targets

PBH has been the topic of a number of recent analyst reports. DA Davidson reaffirmed a "buy" rating and set a $95.00 price target on shares of Prestige Consumer Healthcare in a research note on Monday. Jefferies Financial Group reiterated a "hold" rating and issued a $76.00 target price (up previously from $70.00) on shares of Prestige Consumer Healthcare in a report on Tuesday, September 24th. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $94.20.

Prestige Consumer Healthcare Stock Up 0.8 %

Shares of PBH stock traded up $0.69 during trading hours on Wednesday, reaching $82.32. The company had a trading volume of 455,995 shares, compared to its average volume of 250,267. The stock's fifty day simple moving average is $72.84 and its 200 day simple moving average is $70.00. The company has a market capitalization of $4.07 billion, a P/E ratio of 20.08, a price-to-earnings-growth ratio of 2.30 and a beta of 0.47. The company has a debt-to-equity ratio of 0.61, a quick ratio of 2.10 and a current ratio of 3.56. Prestige Consumer Healthcare Inc. has a twelve month low of $56.61 and a twelve month high of $83.13.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its quarterly earnings results on Thursday, November 7th. The company reported $1.09 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.09. Prestige Consumer Healthcare had a net margin of 18.54% and a return on equity of 12.23%. The firm had revenue of $283.79 million for the quarter, compared to the consensus estimate of $282.09 million. During the same quarter in the previous year, the firm posted $1.07 EPS. The firm's quarterly revenue was down .9% on a year-over-year basis. As a group, sell-side analysts expect that Prestige Consumer Healthcare Inc. will post 4.45 earnings per share for the current fiscal year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.